uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för medicinska vetenskaper, Kardiovaskulär epidemiologi.
Department of Medical and Health Sciences, Linköping University, Linköping, Sweden..
Department of Medical and Health Sciences, Linköping University, Linköping, Sweden..
Department of Medical and Health Sciences, Linköping University, Linköping, Sweden..
Vise andre og tillknytning
2016 (engelsk)Inngår i: Cardiovascular Diabetology, ISSN 1475-2840, E-ISSN 1475-2840, Vol. 15, artikkel-id 40Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

AIMS/HYPOTHESIS: Soluble tumor necrosis factor receptors 1 and 2 (sTNFR1 and sTNFR2) contribute to experimental diabetic kidney disease, a condition with substantially increased cardiovascular risk when present in patients. Therefore, we aimed to explore the levels of sTNFRs, and their association with prevalent kidney disease, incident cardiovascular disease, and risk of mortality independently of baseline kidney function and microalbuminuria in a cohort of patients with type 2 diabetes. In pre-defined secondary analyses we also investigated whether the sTNFRs predict adverse outcome in the absence of diabetic kidney disease.

METHODS: The CARDIPP study, a cohort study of 607 diabetes patients [mean age 61 years, 44 % women, 45 cardiovascular events (fatal/non-fatal myocardial infarction or stroke) and 44 deaths during follow-up (mean 7.6 years)] was used.

RESULTS: Higher sTNFR1 and sTNFR2 were associated with higher odds of prevalent kidney disease [odd ratio (OR) per standard deviation (SD) increase 1.60, 95 % confidence interval (CI) 1.32-1.93, p < 0.001 and OR 1.54, 95 % CI 1.21-1.97, p = 0.001, respectively]. In Cox regression models adjusting for age, sex, glomerular filtration rate and urinary albumin/creatinine ratio, higher sTNFR1 and sTNFR2 predicted incident cardiovascular events [hazard ratio (HR) per SD increase, 1.66, 95 % CI 1.29-2.174, p < 0.001 and HR 1.47, 95 % CI 1.13-1.91, p = 0.004, respectively]. Results were similar in separate models with adjustments for inflammatory markers, HbA1c, or established cardiovascular risk factors, or when participants with diabetic kidney disease at baseline were excluded (p < 0.01 for all). Both sTNFRs were associated with mortality.

CONCLUSIONS/INTERPRETATIONS: Higher circulating sTNFR1 and sTNFR2 are associated with diabetic kidney disease, and predicts incident cardiovascular disease and mortality independently of microalbuminuria and kidney function, even in those without kidney disease. Our findings support the clinical utility of sTNFRs as prognostic markers in type 2 diabetes.

sted, utgiver, år, opplag, sider
2016. Vol. 15, artikkel-id 40
Emneord [en]
Type 2 diabetes; TNF; Laplace regression; Incident cardiovascular disease; Mortality; Inflammation
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-281234DOI: 10.1186/s12933-016-0359-8ISI: 000371581000001PubMedID: 26928194OAI: oai:DiVA.org:uu-281234DiVA, id: diva2:913357
Forskningsfinansiär
Swedish Research CouncilSwedish Heart Lung FoundationMarianne and Marcus Wallenberg FoundationTilgjengelig fra: 2016-03-21 Laget: 2016-03-21 Sist oppdatert: 2017-11-30bibliografisk kontrollert

Open Access i DiVA

fulltext(922 kB)420 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 922 kBChecksum SHA-512
a910a9d25472e7bcd66ca4871e3263b38481703ef3ebb39ad8303f822ac3ba74b0212fdc6766b23021899cedfbfa3955f83ed27b5d8c4e5c36684db52efe0400
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Carlsson, Axel C.Larsson, AndersÄrnlöv, Johan

Søk i DiVA

Av forfatter/redaktør
Carlsson, Axel C.Larsson, AndersÄrnlöv, Johan
Av organisasjonen
I samme tidsskrift
Cardiovascular Diabetology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 420 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 370 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf